Prescription drug · NDA AUTHORIZED GENERIC
misoprostol NDC 71335-9631
Misoprostol 100 ug/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-9631-1 | 71335963101 | 28 TABLET in 1 BOTTLE (71335-9631-1)Marketed from Jan 31, 2023 | |
| 71335-9631-2 | 71335963102 | 90 TABLET in 1 BOTTLE (71335-9631-2)Marketed from Jan 31, 2023 | |
| 71335-9631-3 | 71335963103 | 30 TABLET in 1 BOTTLE (71335-9631-3)Marketed from Jan 31, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- misoprostol
- Generic name (nonproprietary)
- misoprostol
- Active ingredients
- Misoprostol — 100 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 019268
- Marketing start
- Listing expires
- Other FDA classes
- Synthetic (Chemical structure)
- Identifiers
- Product ID 71335-9631_e3b5ce1e-3a29-480b-98a1-4f7bb0af7ad7SPL ID e3b5ce1e-3a29-480b-98a1-4f7bb0af7ad7SPL set ID c842c35f-6a64-4ecc-95a1-41b6d056047eRxCUI 311727UNII 0E43V0BB57
- Pharmacologic class
- Prostaglandin E1 Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335963101followed by a unit qualifier and the quantityPackage 71335-9631-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Misoprostol is indicated for reducing the risk of NSAID (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer. Misoprostol has not been shown to reduce the risk of duodenal ulcers in patients taking NSAIDs. Misoprostol should be taken for the duration of NSAID therapy. Misoprostol has been shown to reduce the risk of gastric ulcers in controlled studies of 3 months' duration. It had no effect, compared to pl…
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 019268
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cytotecmisoprostol | Misoprostol 200 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 0025-1461 |
| misoprostol | Misoprostol 100 ug/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-5007 |
| misoprostol | Misoprostol 200 ug/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-5008 |
| misoprostol | Misoprostol 200 ug/1 | TabletOral | Redpharm Drug | 67296-1936 |
| Cytotecmisoprostol | Misoprostol 100 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 0025-1451 |